top of page
AAO 2024 RETINA SHOWCASE
Moderators: Robert Avery, MD and Allen C. Ho, MD
Panel: Wiley Chambers, MD, Mark Humayun, MD, PhD, and Namrata Saroj, OD
Location: Room E450a
Start | Company | Presenter |
|---|---|---|
1:15 PM | Introduction | Robert Avery, MD |
1:17 PM | Aura Biosciences, Inc. | J. Jill Hopkins, MD, FRCSC, CMO & President of R & D |
1:22 PM | Discussion | |
1:24 PM | Ocular Therapeutix | Peter Kaiser, MD, Chief Development Officer |
1:29 PM | Discussion | |
1:31 PM | ONL Therapeutics | David Zacks, MD, PhD, Co-Founder and Chief Scientific Officer |
1:36 PM | Discussion | |
1:38 PM | Adverum Biotechnologies, Inc. | Laurent Fischer, MD, CEO |
1:43 PM | Discussion | |
1:45 PM | Aviceda Therapeutics Inc. | Tarek Hassan, MD, Chief Development Officer |
1:50 PM | Discussion | |
1:52 PM | Clearside Biomedical, Inc. | Victor Chong, MD, MBA, Chief Medical Officer |
1:57 PM | Discussion | |
1:59 PM | Eyepoint Pharmaceuticals | Jay S. Duker, MD, President & CEO and Board Director |
2:04 PM | Discussion | |
2:06 PM | Oculis | Riad Sherif, MD, CEO |
2:11 PM | Discussion | |
2:13 PM | REGENXBIO, Inc. | Sumie Takahara, Executive Director, Global Product and Market Planning |
2:18 PM | Discussion | |
2:20 PM | 4D Molecular Therapeutics, Inc. | Dhaval B. Desai, Chief Development Officer |
2:25 PM | Discussion | |
2:27 PM | Annexon Biosciences | Doug Love, President & CEO |
2:32 PM | Discussion | |
2:34 PM | Nanoscope Therapeutics | Sam Barone, MD, Chieft Medical Officer |
2:39 PM | Discussion | |
2:41 PM | Kiora Pharmaceuticals | Brian M Strem, PhD, CEO |
2:46 PM | Discussion | |
2:51 PM | Visgenx, Inc. | William Pedranti, CEO |
2:53 PM | Discussion | |
2:55 PM | Conclusion | Allen C. Ho, MD |
bottom of page